AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 158 filers reported holding AKERO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $51 | -1.9% | 2,160 | +4.0% | 0.00% | – |
| Q1 2024 | $52 | -69.6% | 2,077 | -71.6% | 0.00% | -100.0% |
| Q4 2023 | $171 | -55.2% | 7,324 | -3.1% | 0.00% | -66.7% |
| Q3 2023 | $382 | +28.2% | 7,559 | +18.2% | 0.00% | +50.0% |
| Q2 2023 | $298 | +106.9% | 6,393 | +70.1% | 0.00% | +100.0% |
| Q1 2023 | $144 | -42.9% | 3,759 | -18.3% | 0.00% | -50.0% |
| Q4 2022 | $252 | -99.8% | 4,603 | +26.1% | 0.00% | +100.0% |
| Q3 2022 | $124,000 | +275.8% | 3,649 | +4.3% | 0.00% | – |
| Q2 2022 | $33,000 | -41.1% | 3,497 | -10.8% | 0.00% | – |
| Q1 2022 | $56,000 | – | 3,919 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 423,849 | $9,943,498 | 11.19% |
| Propel Bio Management, LLC | 327,752 | $7,689,062 | 4.99% |
| GENERAL ATLANTIC, L.P. | 5,233,989 | $122,789,382 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 625,087 | $14,664,541 | 3.46% |
| Yiheng Capital Management, L.P. | 1,434,179 | $33,645,839 | 2.71% |
| Redmile Group, LLC | 1,614,473 | $37,875,537 | 2.29% |
| Boxer Capital, LLC | 1,676,733 | $39,336,156 | 2.07% |
| RTW INVESTMENTS, LP | 5,431,985 | $127,434,368 | 1.97% |
| Logos Global Management LP | 800,000 | $18,768,000 | 1.52% |
| MPM BioImpact LLC | 385,990 | $9,055,325 | 1.41% |